Nanoparticles, human health hazard and regulation
- PMID: 19726441
- PMCID: PMC2843982
- DOI: 10.1098/rsif.2009.0252.focus
Nanoparticles, human health hazard and regulation
Abstract
New developments in technology usually entail some hazard as well as advantage to a society. Hazard of a material translates into risk by exposure of humans and/or their environment to the agent in question, and risk is reduced by control of exposure, usually guided by regulation based on understanding of the mechanisms of harm. We illustrate risks relating to the causation of diseases associated with exposure to aerosols of combustion particles and asbestos, leading to paradigms of particle toxicity, and discuss analogies with potential exposure to manufactured nanoparticles (NPs). We review the current understanding of the hazard of NPs derived from the new science of nanotoxicology and the limited research to date into human exposure to these particles. We identify gaps in knowledge relating to the properties of NPs that might determine toxicity and in understanding the most appropriate ways both to measure this in the laboratory and to assess it in the workplace. Nevertheless, we point out that physical principles governing the behaviour of such particles allow determination of practical methods of protecting those potentially exposed. Finally, we discuss the early steps towards regulation and the difficulties facing regulators in controlling potentially harmful exposures in the absence of sufficient scientific evidence.
Similar articles
-
Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.Inhal Toxicol. 2007 Jun;19(8):631-43. doi: 10.1080/08958370701353080. Inhal Toxicol. 2007. PMID: 17510836
-
Manufactured nanomaterials: categorization and approaches to hazard assessment.Arch Toxicol. 2014 Dec;88(12):2191-211. doi: 10.1007/s00204-014-1383-7. Epub 2014 Oct 19. Arch Toxicol. 2014. PMID: 25326817 Review.
-
The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.Clin Toxicol (Phila). 2017 Nov;55(9):956-969. doi: 10.1080/15563650.2017.1334913. Epub 2017 Jun 23. Clin Toxicol (Phila). 2017. PMID: 28644057 Review.
-
Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.Int J Immunopathol Pharmacol. 2016 Sep;29(3):343-53. doi: 10.1177/0394632015608933. Epub 2015 Dec 18. Int J Immunopathol Pharmacol. 2016. PMID: 26684639 Free PMC article. Review.
-
Resolving the nanoparticles paradox.Nanomedicine (Lond). 2006 Aug;1(2):229-34. doi: 10.2217/17435889.1.2.229. Nanomedicine (Lond). 2006. PMID: 17716112 Review.
Cited by
-
Protocols for isolation and characterization of nanoparticle biomolecular corona complexes.Front Toxicol. 2024 Jul 23;6:1393330. doi: 10.3389/ftox.2024.1393330. eCollection 2024. Front Toxicol. 2024. PMID: 39109300 Free PMC article.
-
Synthesis and Effect of Hierarchically Structured Ag-ZnO Hybrid on the Surface Antibacterial Activity of a Propylene-Based Elastomer Blends.Materials (Basel). 2018 Mar 1;11(3):363. doi: 10.3390/ma11030363. Materials (Basel). 2018. PMID: 29494511 Free PMC article.
-
Investigation of cellular responses upon interaction with silver nanoparticles.Int J Nanomedicine. 2015 Aug 27;10 Spec Iss(Spec Iss):191-201. doi: 10.2147/IJN.S88508. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26346562 Free PMC article.
-
Anti-inflammatory Nanomedicine for Cardiovascular Disease.Front Cardiovasc Med. 2017 Dec 22;4:87. doi: 10.3389/fcvm.2017.00087. eCollection 2017. Front Cardiovasc Med. 2017. PMID: 29312961 Free PMC article. Review.
-
Superhydrophobicity and conductivity of polyester-conductive fabrics using alkaline hydrolysis.RSC Adv. 2022 Aug 15;12(35):22911-22921. doi: 10.1039/d2ra03996f. eCollection 2022 Aug 10. RSC Adv. 2022. PMID: 36106007 Free PMC article.
References
-
- Aitken R. J., Creely K. S., Tran C. L. 2004. Nanoparticles: an occupational hygiene review. Sudbury, UK: HSE Books RR274.
-
- Artvinli M., Baris Y. I. 1982. Environmental fiber induced pleuro-pulmonary diseases in an Anatolian village: an epidemiologic study. Arch. Environ. Health 37, 177–184. - PubMed
-
- Auchincloss A. H., Diez Roux A. V., Dvonch J. T., Brown P. L., Barr R. G., Daviglus M. L., Goff D. C., Kaufman J. D., O'Neill M. S. 2008. Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-Ethnic Study of Atherosclerosis (MESA). Environ. Health Perspect. 116, 486–491. - PMC - PubMed
-
- Bello D., Hart A. J., Ahn K., Hallock M., Yamamoto N., Garcia E. J., Ellenbecker M. J., Wardle B. L. 2008. Particle exposure levels during CVD growth and subsequent handling of vertically-aligned carbon nanotube films. Carbon 46, 974–977. (10.1016/j.carbon.2008.03.003) - DOI
-
- Bello D., Wardle B., Yamamoto N., Guzman de Villoria R., Garcia E., Hart A., Ahn K., Ellenbecker M., Hallock M. 2009. Exposure to nanoscale particles and fibers during machining of hybrid advanced composites containing carbon nanotubes. J. Nanopart. Res. 11, 231–249. (10.1007/s11051-008-9499-4) - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources